(Q45765887)

http://europepmc.org/abstract/PMC/5353942

15 December 2017

title

IL-15, TIM-3 and NK cells subsets predict responsiveness to anti-CTLA-4 treatment in melanoma patients (English)

1 reference

http://europepmc.org/abstract/PMC/5353942

15 December 2017

author

Mariaelena Capone

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28344869%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Gennaro Ciliberto

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28344869%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Costanza M Cristiani

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28344869%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Elina Staaf

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28344869%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Rosa Sottile

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28344869%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Yago Pico de Coaña

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28344869%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Gabriele Madonna

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28344869%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Valentina Carannante

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28344869%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Domenico Mallardo

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28344869%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Antonio M Grimaldi

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28344869%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Sofia Johansson

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28344869%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Andrea Anichini

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28344869%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Francesco Colucci

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28344869%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Paolo Antonio Ascierto

23

object named as

Paolo A Ascierto

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28344869%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

13

Ester Simeone

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28344869%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

21

Rolf Kiessling

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28344869%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

10

Maria Wolodarski

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28344869%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

1

Rossana Tallerico

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28344869%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

4

Cinzia Garofalo

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28344869%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

17

Elio Gulletta

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28344869%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

24

Ennio Carbone

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28344869%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

author name string

Eleonora Palella

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28344869%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Paolo Frumento

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28344869%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Klas Kärre

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28344869%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

publication date

7 December 2016

1 reference

http://europepmc.org/abstract/PMC/5353942

15 December 2017

published in

OncoImmunology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28344869%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

volume

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28344869%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28344869%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

page(s)

e1261242

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28344869%20AND%20SRC:MED&resulttype=core&format=json

Baseline Biomarkers for Outcome of Melanoma Patients Treated with Pembrolizumab

2 June 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5353942

Increases in Absolute Lymphocytes and Circulating CD4+ and CD8+ T Cells Are Associated with Positive Clinical Outcome of Melanoma Patients Treated with Ipilimumab

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5353942

Baseline Peripheral Blood Biomarkers Associated with Clinical Outcome of Advanced Melanoma Patients Treated with Ipilimumab

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5353942

Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5353942

Immunologic correlates in the course of treatment with immunomodulating antibodies

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5353942

Ipilimumab-dependent cell-mediated cytotoxicity of regulatory T cells ex vivo by nonclassical monocytes in melanoma patients

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5353942

Nivolumab and ipilimumab versus ipilimumab in untreated melanoma

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5353942

Immune Checkpoint Blockade in Cancer Therapy

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5353942

Enrichment of CD56(dim)KIR + CD57 + highly cytotoxic NK cells in tumour-infiltrated lymph nodes of melanoma patients

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5353942

Investigation of serum proteome alterations in human endometriosis.

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5353942

Anchorage independency promoted tumor malignancy of melanoma cells under reattachment through elevated interleukin-8 and CXC chemokine receptor 1 expression

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5353942

Redistribution, hyperproliferation, activation of natural killer cells and CD8 T cells, and cytokine production during first-in-human clinical trial of recombinant human interleukin-15 in patients with cancer

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5353942

Interleukin-15 in the treatment of cancer

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5353942

Natural killer cells are essential for the ability of BRAF inhibitors to control BRAFV600E-mutant metastatic melanoma

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5353942

Anti-CTLA-4 therapy broadens the melanoma-reactive CD8+ T cell response.

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5353942

Reversal of NK-cell exhaustion in advanced melanoma by Tim-3 blockade

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5353942

Enhancement of tumor-reactive cytotoxic CD4+ T cell responses after ipilimumab treatment in four advanced melanoma patients

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5353942

Therapeutic applications: natural killer cells in the clinic.

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5353942

Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5353942

The engagement of CTLA-4 on primary melanoma cell lines induces antibody-dependent cellular cytotoxicity and TNF-α production

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5353942

Biomarkers on melanoma patient T cells associated with ipilimumab treatment

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5353942

Tim-3 marks human natural killer cell maturation and suppresses cell-mediated cytotoxicity

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5353942

Tim-3 is an inducible human natural killer cell receptor that enhances interferon gamma production in response to galectin-9

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5353942

Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5353942

Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumors

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5353942

Mature natural killer cells with phenotypic and functional alterations accumulate upon sustained stimulation with IL-15/IL-15Ralpha complexes

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5353942

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5353942

NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo.

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5353942

CTLA-4 control over Foxp3+ regulatory T cell function

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5353942

The role of regulatory T cells in the control of natural killer cells: relevance during tumor progression

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5353942

Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5353942

Enhancement of antitumor immunity by CTLA-4 blockade

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5353942

CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5353942

„Natural” killer cells in the mouse. II. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Characteristics of the killer cell

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5353942

Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy.

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5353942

„Natural”︁ killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5353942

Reversal of natural killer cell exhaustion by TIM-3 blockade

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5353942

Increased serum levels of interleukin-15 correlate with negative prognostic factors in extranodal NK/T cell lymphoma.

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5353942

Biomarkers for immunostimulatory monoclonal antibodies in combination strategies for melanoma and other tumor types

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5353942

Ipilimumab increases activated T cells and enhances humoral immunity in patients with advanced melanoma.

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5353942

Orthogonal projections to latent structures (O-PLS)

15 August 2018

1 reference

Crossref

https://api.crossref.org/works/10.1080%2F2162402X.2016.1261242

Immunological and biological changes during ipilimumab treatment and their potential correlation with clinical response and survival in patients with advanced melanoma

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1080%2F2162402X.2016.1261242

Synergistic effects of CTLA-4 blockade with tremelimumab and elimination of regulatory T lymphocytes in vitro and in vivo

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5353942

Prognostic significance of natural killer cell activity in patients with gastric carcinoma: a multivariate analysis

3 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28344869

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1080/2162402X.2016.1261242

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28344869%20AND%20SRC:MED&resulttype=core&format=json

release_uk2tjrxjzrh6bjnkzi36hf3wyu

2 June 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/uk2tjrxjzrh6bjnkzi36hf3wyu

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28344869%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

PubMed publication ID

28344869

1 reference